Opko Health Inc (OPK) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Opko Health Inc stock $1.54, price $1.62, that is 4.9% below the price, quality 38 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Opko Health Inc
OPK · USRising price, but the stock is already about fairly priced and weak company: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
60‑month range $0.8655 – $5.15 · fair‑value band $1.15 – $1.92 · the $1.62 price screens above the $1.54 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether Opko Health is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company operates in two segments, Pharmaceutical and Diagnostics.
Show moreShow less
The Pharmaceutical segment develops MDX2001, a tetra-specific antibody targeting several types of solid tumors in Phase 1 clinical trials; MDX2003, a tetra-specific antibody targeting two antigens for hematological tumors in Phase 1 clinical trials; and MDX2004, a trispecific immune modulator to rebuild and sustain the patient's own immune system.
This segment also engages in the development of Epstein Barr Virus vaccine; Rayaldee, a patented extended-release product for oral administration containing 30 mcg of a prohormone; OPK-88006 oral and injectable product to regulate blood glucose and reduce body weight; NGENLA, recombinant human growth hormone product developed for the long-term treatment of pediatric patients with growth hormone deficiency.
The Diagnostics segment offers laboratory testing services, such as detection, diagnosis, evaluation, monitoring, and treatment of diseases, as well as esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare under the BioReference brand; and 4Kscore test.
OPKO Health, Inc. was founded in 2006 and is headquartered in Miami, Florida.
Stock analysis
Opko Health Inc (OPK) currently trades at $1.62, while our estimate is $1.54, so the stock looks roughly fairly valued today (gap 5.2%).
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: $1.15 (bear) to $1.92 (bull), the price of $1.62 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Opko Health Inc reported revenue of $607M in FY2025 versus $1.8B in FY2021, a compound −23.5%/yr. Reported net income was −$226M in FY2025.
Key figures
Market cap $1.2B Small · P/S ratio 2.18 · EPS (TTM) $−0.1600 · Net margin −37.2% · Return on equity −5.9% · Return on assets (EBIT) −7.1% (5-year average) · Operating margin −15.3% · Revenue (TTM) $588M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (medium confidence).
What moves the price
The share trades about 8% below its 52-week high and 47% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −9% fair-value upside, at −5%, OPK screens cheaper than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Insider trades
In the last 6 months, one officer or director sold shares worth $24,577 and none bought.
- SaleJohn A PaganelliDirector13,601 shares at $1.81$24,577Nov 5, 2026
- BuyJohn A PaganelliDirector10,000 shares at $1.14$11,400Mar 20, 2026
- BuyFrost Gamma Investments Trust10% owner4× since Nov 18, 2025: 2,273,300 shares, avg. $1.31$3.0MNov 21, 2025
Plus 2 other filings such as grants, option exercises or tax withholding. They are not market purchases or sales.
Sales are often planned (taxes, diversification, 10b5-1 plans). Purchases with their own money are seen as the stronger sign. For information only: not part of the quality score or Fair Value.
Source: SEC Form 4, as of Nov 16, 2026. All filings at the SEC ↗
Revenue & earnings trend
Watch OPK, get fair value alerts →
Compare Opko Health Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 151 stocks
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Debt-to-equity by industry
- Price/FCF by industry
- Stock screener with 62 metrics
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Illumina, Inc ILMN | $198.00 | $227.71 | +15% | vs OPK |
| WuXi AppTec Co 603259 | ¥144.41 | ¥164.66 | +14% | vs OPK |
| IQVIA Holdings IQV | $264.73 | $291.63 | +10% | vs OPK |
| Thermo Fisher Scientific Inc TMO | $691.33 | $686.04 | −1% | vs OPK |
| Danaher Corporation DHR | $229.91 | $209.18 | −9% | vs OPK |
| IDEXX Laboratories, Inc IDXX | $700.65 | $496.48 | −29% | vs OPK |
| Lonza Group LONN | CHF 670.20 | CHF 259.80 | −61% | vs OPK |
| Mettler-Toledo International Inc MTD | $1,727 | $655.06 | −62% | vs OPK |
| Agilent Technologies, Inc A | $172.92 | $64.20 | −63% | vs OPK |
| Waters Corporation WAT | $453.42 | $91.26 | −80% | vs OPK |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Opko Health Inc (OPK) overvalued or undervalued?
What is the fair value of OPK?
What is the quality score of OPK?
What is the price target for Opko Health Inc (OPK)?
What is the Opko Health Inc stock forecast for 2026?
What is the revenue of Opko Health Inc (OPK)?
What is the intrinsic value of Opko Health Inc (OPK)?
Is Opko Health Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of OPK?
How much is Opko Health Inc worth?
What do the bullish and bearish scenarios say about OPK?
What is the PEG ratio of OPK?
How solid is the balance sheet of Opko Health Inc (OPK)?
How far is OPK from its 52-week high?
Which stocks are comparable to Opko Health Inc?
Is Opko Health Inc stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Opko Health Inc (OPK)?
What should I pay attention to with Opko Health Inc right now?
Key figures of Opko Health Inc
How large is the market capitalisation of Opko Health Inc (OPK)?
What is the P/S ratio of Opko Health Inc (OPK)?
What are the earnings per share of Opko Health Inc (OPK)?
What is the net margin of Opko Health Inc (OPK)?
What is the return on equity of Opko Health Inc (OPK)?
What is the EBIT return on assets of Opko Health Inc (OPK)?
What is the operating margin of Opko Health Inc (OPK)?
How fast is revenue growing at Opko Health Inc (OPK)?
How fast are earnings growing at Opko Health Inc (OPK)?
How much free cash flow does Opko Health Inc (OPK) generate?
How much net debt does Opko Health Inc (OPK) carry?
Watch Opko Health Inc in the live analysis
One click puts Opko Health Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.